• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells.基于癌症基因组图谱数据集,通过基因分析对胸腺瘤相关重症肌无力中异常表达基因的分析:聚焦于T细胞。
J Thorac Dis. 2019 Jun;11(6):2315-2323. doi: 10.21037/jtd.2019.06.01.
2
Identification of Hub Genes and Analysis of their Regulatory miRNAs in Patients with Thymoma Associated Myasthenia Gravis Based on TCGA Database.基于TCGA数据库的胸腺瘤伴重症肌无力患者关键基因的鉴定及其调控miRNA的分析
Microrna. 2025;14(1):49-58. doi: 10.2174/0122115366299210240823062457.
3
The LINC00452/miR-204/CHST4 Axis Regulating Thymic Tregs Might Be Involved in the Progression of Thymoma-Associated Myasthenia Gravis.LINC00452/miR-204/CHST4轴调控胸腺调节性T细胞可能参与胸腺瘤相关重症肌无力的进展。
Front Neurol. 2022 Mar 30;13:828970. doi: 10.3389/fneur.2022.828970. eCollection 2022.
4
Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.胸腺瘤相关重症肌无力(TAMG):不同胸腺瘤组织类型中与 MG 状态相关的功能途径的差异表达。
Front Immunol. 2020 Apr 16;11:664. doi: 10.3389/fimmu.2020.00664. eCollection 2020.
5
A new gene signature associated with disulfidptosis that forecasts myasthenia gravis and suggests infiltration of immune microenvironment in thymoma patients.一种与二硫键介导的程序性坏死相关的新基因特征,可预测重症肌无力,并提示胸腺瘤患者免疫微环境的浸润情况。
Heliyon. 2024 Apr 15;10(8):e29650. doi: 10.1016/j.heliyon.2024.e29650. eCollection 2024 Apr 30.
6
Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.微小RNA-125a-5p在胸腺瘤相关重症肌无力中的表达改变及其对Jurkat细胞中叉头框蛋白3表达的下调作用
Immunol Lett. 2016 Apr;172:47-55. doi: 10.1016/j.imlet.2016.02.005. Epub 2016 Feb 11.
7
Integrated proteomics and metabolomics analysis reveals hubs protein and network alterations in myasthenia gravis.整合蛋白质组学和代谢组学分析揭示重症肌无力中的枢纽蛋白和网络改变。
Aging (Albany NY). 2022 Jul 8;14(13):5417-5426. doi: 10.18632/aging.204156.
8
Two types of immune infiltrating cells and six hub genes can predict the occurrence of myasthenia gravis in patients with thymoma.两种免疫浸润细胞和六个枢纽基因可预测胸腺瘤患者重症肌无力的发生。
Bioengineered. 2021 Dec;12(1):5004-5016. doi: 10.1080/21655979.2021.1958634.
9
Thymoma related myasthenia gravis in humans and potential animal models.人类胸腺瘤相关重症肌无力及潜在动物模型。
Exp Neurol. 2015 Aug;270:55-65. doi: 10.1016/j.expneurol.2015.02.010. Epub 2015 Feb 18.
10
cFLIP overexpression in T cells in thymoma-associated myasthenia gravis.胸腺瘤相关重症肌无力患者 T 细胞中 cFLIP 的过表达。
Ann Clin Transl Neurol. 2015 Sep;2(9):894-905. doi: 10.1002/acn3.210. Epub 2015 Jul 22.

引用本文的文献

1
The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.胸腺上皮肿瘤的分子特征:全面综述。
Int J Mol Sci. 2024 Jan 26;25(3):1554. doi: 10.3390/ijms25031554.
2
DCAF12 and HSPA1A May Serve as Potential Diagnostic Biomarkers for Myasthenia Gravis.钙调蛋白依赖性丝氨酸型蛋白磷酸酶 12 与热休克蛋白家族 A 成员 1A 可能作为重症肌无力的潜在诊断生物标志物。
Biomed Res Int. 2022 May 24;2022:8587273. doi: 10.1155/2022/8587273. eCollection 2022.
3
Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis.通过多组学分析鉴定胸腺瘤的分子特征和新的预后靶点
Biomed Res Int. 2021 May 19;2021:5587441. doi: 10.1155/2021/5587441. eCollection 2021.
4
Autoimmune disorders and paraneoplastic syndromes in thymoma.胸腺瘤中的自身免疫性疾病和副肿瘤综合征。
J Thorac Dis. 2020 Dec;12(12):7571-7590. doi: 10.21037/jtd-2019-thym-10.
5
Correlation of genomic alterations and PD-L1 expression in thymoma.胸腺瘤中基因组改变与程序性死亡受体配体1(PD-L1)表达的相关性
J Thorac Dis. 2020 Dec;12(12):7561-7570. doi: 10.21037/jtd-2019-thym-13.
6
Pathology of thymoma-where are we today?胸腺瘤的病理学——我们如今处于什么阶段?
J Thorac Dis. 2020 Dec;12(12):7545-7552. doi: 10.21037/jtd-2019-thym-04.
7
Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma.BTLA 标签变异与食管胃结合部腺癌风险的研究。
Biosci Rep. 2019 Dec 20;39(12). doi: 10.1042/BSR20191770.

本文引用的文献

1
Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis.肺表面活性蛋白基因 SFTPA1、SFTPA2、SFTPB、SFTPC 和 SFTPD 与囊性纤维化的遗传关联。
Front Immunol. 2018 Oct 2;9:2256. doi: 10.3389/fimmu.2018.02256. eCollection 2018.
2
ATM in breast and brain tumors: a comprehensive review.乳腺癌和脑肿瘤中的ATM:全面综述。
Cancer Biol Med. 2018 Aug;15(3):210-227. doi: 10.20892/j.issn.2095-3941.2018.0022.
3
The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy.趋化因子受体 CCR7 是类风湿关节炎治疗的一个有前途的靶点。
Cell Mol Immunol. 2019 Oct;16(10):791-799. doi: 10.1038/s41423-018-0056-5. Epub 2018 Jul 4.
4
Increased frequency of CCR7CD4 T cells from patients with primary Sjögren's syndrome: An indicator of disease activity rather than of damage severity.原发性干燥综合征患者 CCR7+CD4+T 细胞频率增加:疾病活动的指标而非损伤严重程度的指标。
Cytokine. 2018 Oct;110:9-17. doi: 10.1016/j.cyto.2018.04.015. Epub 2018 Apr 21.
5
CCR7 on CD4 T Cells Plays a Crucial Role in the Induction of Experimental Autoimmune Encephalomyelitis.CCR7 在 CD4 T 细胞中在诱导实验性自身免疫性脑脊髓炎中起着关键作用。
J Immunol. 2018 Apr 15;200(8):2554-2562. doi: 10.4049/jimmunol.1701419. Epub 2018 Mar 16.
6
T Cell Subsets in the Germinal Center: Lessons from the Macaque Model.生发中心中的 T 细胞亚群:来自猕猴模型的启示。
Front Immunol. 2018 Feb 26;9:348. doi: 10.3389/fimmu.2018.00348. eCollection 2018.
7
Adenovirus-Mediated CCR7 and BTLA Overexpression Enhances Immune Tolerance and Migration in Immature Dendritic Cells.腺病毒介导的CCR7和BTLA过表达增强未成熟树突状细胞的免疫耐受性和迁移能力。
Biomed Res Int. 2017;2017:3519745. doi: 10.1155/2017/3519745. Epub 2017 Mar 14.
8
Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.BTLA和HVEM的免疫调节功能决定胸腺外调节性T细胞的诱导及树突状细胞介导的耐受性。
Immunity. 2016 Nov 15;45(5):1066-1077. doi: 10.1016/j.immuni.2016.10.008. Epub 2016 Oct 25.
9
Death receptor 3 mediates necroptotic cell death.死亡受体3介导坏死性凋亡细胞死亡。
Cell Mol Life Sci. 2017 Feb;74(3):543-554. doi: 10.1007/s00018-016-2355-2. Epub 2016 Sep 3.
10
B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.多发性硬化症中的 B 淋巴细胞:Bregs 和表达 BTLA/CD272 的-CD19+ 淋巴细胞调节疾病严重程度。
Sci Rep. 2016 Jul 14;6:29699. doi: 10.1038/srep29699.

基于癌症基因组图谱数据集,通过基因分析对胸腺瘤相关重症肌无力中异常表达基因的分析:聚焦于T细胞。

The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells.

作者信息

Xi Jianying, Wang Liang, Yan Chong, Song Jie, Song Yang, Chen Ji, Zhu Yongjun, Chen Zhiming, Jin Chun, Ding Jianyong, Zhao Chongbo

机构信息

Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China.

Department of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.

出版信息

J Thorac Dis. 2019 Jun;11(6):2315-2323. doi: 10.21037/jtd.2019.06.01.

DOI:10.21037/jtd.2019.06.01
PMID:31372268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6626793/
Abstract

BACKGROUND

Myasthenia gravis (MG) is a group of autoimmune disease which could be accompanied by thymoma. Many differences have been observed between thymoma-associated MG (TAMG) and non-MG thymoma (NMG). However, the molecular difference between them remained unknown. This study aimed to explore the differentially expressed genes (DEGs) between the two categories and to elucidate the possible pathogenesis of TAMG further.

METHODS

DEGs were calculated using the RNA-Sequencing data from 11 TAMG and 10 NMG in The Cancer Genome Atlas (TCGA) database. GeneAnalytics was performed to characterize the associations between DEGs and tissues and cells, diseases, gene ontology (GO) terms, pathways, phenotypes, and drug/compounds, respectively. Genes related to T cells were sorted out using LifeMapDiscovery Cells and Tissues Database. Genes directly related to the phenotype of autoimmune diseases that were identified by VarElect were validated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).

RESULTS

The expression level of 169 genes showed a significant difference between the two groups, with 94 up-regulated and 75 down-regulated. Overexpression of six genes (, , , , , ), which are expressed in T cells and directly related to autoimmune disease through VarElect, was identified. The overexpression of soluble BTLA (sBTLA) (P=0.027), CCR7 (P=0.0018), TNFRSF25 (P=0.0013) and ANKRD55 (P=0.0026) was validated by RT-qPCR in thymoma tissues from our center.

CONCLUSIONS

Overexpression of sBTLA, CCR7, TNFRSF25 and ANKRD55 was identified and validated by RT-qPCR, which could partly explain the underlying pathogenesis in TAMG.

摘要

背景

重症肌无力(MG)是一组可伴有胸腺瘤的自身免疫性疾病。胸腺oma相关MG(TAMG)和非MG胸腺瘤(NMG)之间已观察到许多差异。然而,它们之间的分子差异仍然未知。本研究旨在探讨这两类之间的差异表达基因(DEG),并进一步阐明TAMG的可能发病机制。

方法

使用来自癌症基因组图谱(TCGA)数据库中11例TAMG和10例NMG的RNA测序数据计算DEG。分别进行基因分析以表征DEG与组织和细胞、疾病、基因本体(GO)术语、途径、表型以及药物/化合物之间的关联。使用LifeMapDiscovery细胞和组织数据库筛选与T细胞相关的基因。通过VarElect鉴定的与自身免疫性疾病表型直接相关的基因通过逆转录定量聚合酶链反应(RT-qPCR)进行验证。

结果

两组之间169个基因的表达水平存在显著差异,其中94个上调,75个下调。鉴定出六个在T细胞中表达并通过VarElect与自身免疫性疾病直接相关的基因(、、、、、)的过表达。通过RT-qPCR在我们中心的胸腺瘤组织中验证了可溶性BTLA(sBTLA)(P=0.027)、CCR7(P=0.0018)、TNFRSF25(P=0.0013)和ANKRD55(P=0.0026)的过表达。

结论

通过RT-qPCR鉴定并验证了sBTLA、CCR7、TNFRSF25和ANKRD55的过表达,这可能部分解释了TAMG的潜在发病机制。